Paracetamol tablets supplied to the Primary Health Center (PHC) in Kotekar, Karnataka, have been recalled following complaints, prompting health authorities to initiate a comprehensive investigation into the matter. The recall was deemed necessary to ensure the safety and well-being of the recipients of the medication.
The decision to recall the paracetamol tablets came after reports of complaints regarding the quality and efficacy of the supplied medicine. Concerns were raised by individuals who had received the tablets from the PHC, emphasizing the need for immediate action to address potential issues.
Health authorities have swiftly responded by launching a thorough investigation into the complaints, aiming to identify the root cause and determine whether the tablets meet the required safety and quality standards. The recall process is being conducted in accordance with established protocols to maintain public health and safety.
Additionally, the concerned authorities have urged individuals who have received the paracetamol tablets from the Kotekar PHC to return them and refrain from consuming the medication until further notice. This precautionary measure aims to prevent any potential health risks that may arise from the alleged issues associated with the tablets.
The incident has highlighted the importance of stringent quality control measures in pharmaceutical distribution and the need for timely action when concerns about medication safety are raised. The health authorities remain committed to ensuring the provision of safe and effective medicines to the public, prioritizing their health and well-being above all else. Further updates on the investigation and the status of the recalled medication will be communicated to the public as they become available.
